The FDA continues to recommend that Hospira’s potassium phosphates not be used in parenteral nutrition for pediatric patients. The Food and Drug Administration (FDA) has issued an updated warning ...
FDA-approved option for adult and pediatric patients available in 15 mM per 5 mL, 45 mM per 15 mL and 150 mM per 50 mL presentations LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today ...
Credit: Getty Images. The FDA has issued a safety alert regarding the use of unapproved potassium phosphates drug products in pediatric patients. The Food and Drug Administration (FDA) has issued a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results